Bystolic

See the following -

Top Medicare Prescribers Rake In Speaking Fees From Drugmakers

Charles Ornstein, Tracy Weber, and Jennifer LaFleur | ProPublica | June 25, 2013

When the blood pressure drug Bystolic hit the market in 2008, it faced a crowded field of cheap generics. So its maker, Forest Laboratories, launched a promotional assault [...]. It flooded the offices of health professionals with drug reps, and it hired doctors to persuade their peers to choose Bystolic — even though the drug hadn't proved more effective than competitors. Read More »

You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs

Martha Rosenberg | The Influence | July 18, 2016

At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...

Read More »